SCOTT, B. Et Al. 2004. ICOS is essential for the development of experimental autoimmune myasthenia gravis. JOURNAL OF NEUROIMMUNOLOGY , vol.153 , 16-25.

SCOTT, B., YANG, H., Tuzun, E., DONG, C., FLAVELL, R., & CHRISTADOSS, P., (2004). ICOS is essential for the development of experimental autoimmune myasthenia gravis. JOURNAL OF NEUROIMMUNOLOGY , vol.153, 16-25.

SCOTT, BG Et Al. "ICOS is essential for the development of experimental autoimmune myasthenia gravis," JOURNAL OF NEUROIMMUNOLOGY , vol.153, 16-25, 2004

SCOTT, BG Et Al. "ICOS is essential for the development of experimental autoimmune myasthenia gravis." JOURNAL OF NEUROIMMUNOLOGY , vol.153, pp.16-25, 2004

SCOTT, B. Et Al. (2004) . "ICOS is essential for the development of experimental autoimmune myasthenia gravis." JOURNAL OF NEUROIMMUNOLOGY , vol.153, pp.16-25.

@article{article, author={BG SCOTT Et Al. }, title={ICOS is essential for the development of experimental autoimmune myasthenia gravis}, journal={JOURNAL OF NEUROIMMUNOLOGY}, year=2004, pages={16-25} }